A phase 3 trial failed to find progression-free survival among lung cancer patients, Bristol Myers Squibb said May 10. 

As drug shortages continue to affect day-to-day pharmacy operations and patient care, pharmacy leaders are turning to several strategies to help manage supply and mitigate impacts.

In a small trial of 14 patients, a CRISPR gene editing therapy improved vision among 11 participants, according to research led by a Mass General Brigham clinician. 

An FDA panel of independent advisers is set to consider the first potential new post-traumatic stress disorder treatment in 25 years — MDMA — NBC News reported May 7.

A boy has died in Pfizer's phase 2 study of its gene therapy candidate for Duchenne muscular dystrophy, a rare genetic disorder that primarily affects boys, according to a patient advocacy group. 

Patients of health systems that partner with RxLink will now receive pricing information on prescription medications offered through Mark Cuban's Cost Plus Drugs Co. 

Pharmacists are not often consulted in decision-making conversations about atrial fibrillation patients, the American Heart Association said, so the organization is working to engage pharmacists in AFib care. 

Duarte, Calif.-based City of Hope is collaborating with medical technology company Becton Dickinson to launch a new pharmacist residency program. 

On May 6, Pfizer appointed a former Citigroup executive as its chief strategy and innovation officer, executive vice president.

Following an HHS proposal, a Senate committee penned a bill to incentivize hospitals and other healthcare supply chain stakeholders for their drug shortage mitigation strategies, including stockpiles.